Ignite Creation Date:
2025-12-24 @ 3:42 PM
Ignite Modification Date:
2025-12-27 @ 4:31 AM
Study NCT ID:
NCT01241292
Status:
COMPLETED
Last Update Posted:
2018-02-15
First Post:
2010-11-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Japanese Study of BMS-901608 (Elotuzumab) in Combination With Lenalidomide and Low Dose Dexamethasone
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-01-14
Start Date Type:
ACTUAL
Primary Completion Date:
2014-02-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-01-16
Completion Date Type:
ACTUAL
First Submit Date:
2010-11-04
First Submit QC Date:
None
Study First Post Date:
2010-11-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-12-16
Results First Submit QC Date:
None
Results First Post Date:
2016-01-22
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-01-19
Last Update Post Date:
2018-02-15
Last Update Post Date Type:
ACTUAL